首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1623505

解剖病理學市場規模（按產品/服務、應用、最終用戶、地區、範圍和預測）

Anatomic Pathology Market Size By Product And Service, By Application, By End-User, By Geographic Scope And Forecast

出版日期: 2024年07月05日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

解剖病理學市場規模及預測

2024 年解剖病理學市場規模價值為 205.4 億美元，預計到 2031 年將達到 319.2 億美元，預測期內（2024-2031 年）的複合年增長率為 5.67%。

解剖病理學是病理學的一個分支，透過檢查器官和組織來診斷疾病。

該領域的基礎是視覺檢查，涉及仔細評估組織的宏觀特徵、大小、形狀、顏色和一致性。

然後仔細處理樣品並準備進行顯微分析。薄切片用特殊染料染色以突出細胞和結構細節。

病理學家，經過有關疾病過程和組織形態學的廣泛培訓的醫生，在顯微鏡下觀察這些切片。病理學家仔細評估微觀特徵，尋找可能解釋潛在疾病的特徵性異常。

解剖病理學市場動態

影響解剖病理學市場的關鍵市場動態

主要市場驅動因子

增加疾病負擔：

疾病負擔加重：慢性病尤其是癌症發生率的增加是一個主要推動因素。解剖病理學在診斷這些疾病中起著關鍵作用，促使對相關服務和產品的需求增加。

越來越重視個人化醫療：

個人化醫療涉及根據個人的基因和分子組成製定治療計劃。解剖病理學在透過先進技術識別這些目標方面發揮關鍵作用，從而推動了市場成長。

技術進步：

數位病理學的出現正在改變這個領域。數位化允許對幻燈片進行遠端分析，提高工作流程效率並促進病理學家之間的合作。此外，免疫組織化學和分子檢測的進步正在提高診斷的準確性，進一步支持市場擴張。

增加政府資助和報銷措施：

政府對醫療保健基礎設施的支持不斷增加，以及促進疾病早期發現的舉措，促進了市場的成長。鼓勵使用先進診斷技術的報銷政策也發揮著重要作用。

主要問題

嚴格的監理要求：

新的診斷測試和設備的開發和批准需要嚴格的監管監督。這既費時又昂貴，阻礙了新技術快速轉化為臨床實踐。

缺乏人力：

全球疾病負擔不斷加重，加上合格病理學家數量有限，給解剖病理學部門帶來了壓力。工作人員短缺導致診斷延遲並降低整個醫療保健系統的效率。

整合成本與資料安全問題：

引入數位病理學等尖端技術需要大量的基礎設施投資。此外，需要有效解決與數位病理學工作流程相關的資料安全和隱私問題。

贖回壓力：

醫療保健付款人不斷尋求成本控制。先進的診斷測試可以改善患者的治療效果，但獲得這些測試的足夠報銷可能具有課題性，從而限制了它們在某些情況下的可用性。

主要趨勢：

數位病理學應用的激增：

數位病理學工作流程的採用正在加速。該技術促進了遠端幻燈片分析，使地理位置分散的病理學家能夠協作並提高工作流程效率。數位幻燈片可以輕鬆儲存和共享，從而改善溝通和案例討論。

進階診斷整合：

解剖病理學越來越多地融入免疫組織化學和分子生物學測試等先進的診斷技術。這些進步將提高疾病診斷的準確性，從而實現更有針對性的治療方法並改善患者的治療效果。這一趨勢是由個人化醫療日益增長的興趣所推動的。

工作流程最佳化：

解剖病理學實驗室正在努力簡化其工作流程。這包括自動化日常任務、改進設備和軟體整合以及採用數位病理學解決方案。這些進步旨在提高效率並減少診斷所需的時間。

新興市場具有成長潛力：

中國和印度等新興經濟體為解剖病理學市場提供了巨大的成長機會。這是由於醫療成本上升、人們對慢性病的認識增強以及醫療基礎設施投資增加等因素所造成的。

解剖病理學市場區域分析

北美：

北美目前在全球解剖病理學市場中佔據主導地位，預計在可預見的未來將繼續保持領先地位。

該地區是主要解剖病理學公司的所在地，並擁有完善的醫療保健體系。

北美的政府機構正在積極支持病理學家培訓計劃和早期疾病檢測計劃。

北美的醫院和臨床實驗室通常擁有先進的技術和基礎設施。這種強大的基礎設施將促進新的診斷工具和技術的無縫整合。

北美慢性病（尤其是癌症）發生率的不斷增加，推動了對解剖病理學服務的需求。

亞太地區：

亞太地區 (APAC) 是解剖病理學的一個不斷增長的市場，並顯示出巨大的成長潛力。

與全球趨勢一致，亞太地區慢性病，尤其是癌症的發生率正在上升。這使得診斷程序的數量激增，從而推動了對解剖病理學服務和產品的需求。

許多亞太國家人口老化迅速，增加了罹患慢性病的風險，也進一步增加了對先進診斷工具的需求。

亞太地區各國政府正在加大對醫療保健基礎設施的投資。這包括建立配備最新技術的新醫院和實驗室，促進採用先進的解剖病理學技術。

許多亞太地區國家的可支配收入不斷增加，促使醫療保健支出增加。這種在醫療保健上花費的意願正在推動解剖病理學服務和技術市場的發展。

The emergence of digital pathology is transforming the field. Digitalization allows for remote analysis of slides, improves workflow efficiency, and facilitates collaboration among pathologists. Additionally, advancements in immunohistochemistry and molecular testing are enhancing diagnostic accuracy, further driving market expansion.

Increased Government Funding and Reimbursement Initiatives:

Growing government support for healthcare infrastructure and initiatives promoting early disease detection are contributing to market growth. Reimbursement policies that incentivize the use of advanced diagnostic techniques are also playing a significant role.

Key Challenges:

Stringent Regulatory Requirements:

The development and approval of new diagnostic tests and equipment are subject to rigorous regulatory oversight. This can be a lengthy and expensive process, hindering the swift integration of novel technologies into clinical practice.

Workforce Shortages:

A growing global burden of disease coupled with a limited number of qualified pathologists creates a strain on anatomic pathology departments. This shortage can lead to delays in diagnoses and hinder the overall efficiency of the healthcare system.

Integration Costs and Data Security Concerns:

The adoption of advanced technologies like digital pathology necessitates significant infrastructure investments. Additionally, concerns regarding data security and privacy associated with digital pathology workflows need to be addressed effectively.

Reimbursement Pressures:

Healthcare payors are constantly seeking to control costs. While advanced diagnostic tests can improve patient outcomes, obtaining adequate reimbursement for these tests can be challenging, limiting their accessibility in certain settings.

Key Trends:

Surge in Digital Pathology Adoption:

Digital pathology workflows are being increasingly embraced. This technology facilitates remote slide analysis, enabling collaboration among geographically dispersed pathologists and improving workflow efficiency. The ability to store and share digital slides effortlessly fosters improved communication and case consultations.

Integration of Advanced Diagnostics:

Anatomic pathology is witnessing the integration of advanced diagnostic techniques like immunohistochemistry and molecular testing. These advancements offer greater precision in disease diagnosis, allowing for more targeted treatment approaches and improved patient outcomes. This trend is being driven by the growing focus on personalized medicine.

Focus on Workflow Optimization:

Efforts are being directed towards streamlining workflows in anatomic pathology laboratories. This includes automating routine tasks, improving the integration of instruments and software, and adopting digital pathology solutions. These advancements aim to enhance efficiency and reduce turnaround times for diagnoses.

Emerging Markets Offer Growth Potential:

Developing economies like China and India present significant growth opportunities for the anatomic pathology market. This is due to factors such as rising healthcare expenditure, increasing awareness of chronic diseases, and growing investments in healthcare infrastructure.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Anatomic Pathology Market Regional Analysis

Here is a more detailed regional analysis of the anatomic pathology market:

North America:

North America currently holds the dominant position in the global anatomic pathology market, and its leadership is expected to continue for the foreseeable future.

The region boasts a well-established healthcare system with a concentration of leading companies in the anatomic pathology space.

Government agencies in North America actively support initiatives related to pathologist training programs and early disease detection programs.

Hospitals and clinical laboratories in North America are generally well-equipped with advanced technology and infrastructure. This robust infrastructure facilitates the seamless integration of novel diagnostic tools and techniques.

The growing incidence of chronic diseases, particularly cancer, in North America fuels the demand for anatomic pathology services.

Asia Pacific:

The Asia Pacific (APAC) region represents a growing market for anatomic pathology, exhibiting significant growth potential.

Similar to global trends, APAC experiences a growing prevalence of chronic diseases, particularly cancer. This necessitates a surge in diagnostic procedures, driving demand for anatomic pathology services and products.

Rapid population aging in many APAC countries translates into a higher risk of chronic diseases, further amplifying the need for advanced diagnostic tools.

Governments across APAC are increasingly investing in healthcare infrastructure development. This includes the establishment of new hospitals and laboratories equipped with modern technology, fostering the adoption of advanced anatomic pathology techniques.

Disposable incomes are rising in many APAC countries, leading to increased healthcare expenditure. This willingness to spend on healthcare fuels the market for anatomic pathology services and technologies.

Anatomic Pathology Market Segmentation Analysis

The Anatomic Pathology Market is segmented based on Product And Service, Application, End-User, And Geography.

Anatomic Pathology Market, By Product And Service

Instruments
Consumables
Services

Based on Product & Service, the market is divided into instruments, consumables, and services. The service segment dominates the market with the largest market share in 2019 and is expected to register the highest CAGR during the forecast period. This dominance is attributed to factors such as the availability of reimbursement for diagnostic tests, rapid growth in the geriatric population, and increasing incidence of cancer and other chronic diseases.

Anatomic Pathology Market, By Application

Disease Diagnosis
Drug Discovery And Development
Others

Based on Application, the market is segmented into disease diagnosis, drug discovery and development, and others. In 2019, the disease diagnosis segment held the largest market share. This growth can be attributed to the rapid increase in the geriatric population and the rising incidence of cancer and other chronic diseases.

Anatomic Pathology Market, By End-User

Hospitals
Diagnostic Laboratories
Research Laboratories
Others

Based on end-user, the market is segmented into hospitals, diagnostic laboratories, research laboratories, and others. Diagnostic laboratories, followed by hospitals, have been dominating the market in terms of market share.

Anatomic Pathology Market, By Geography

North America
Europe
Asia Pacific
Rest of The World

Based on Geography, the anatomic pathology market is classified into North America, Europe, Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest market share, followed by Europe. The major factors driving the growth in the Anatomic Pathology Market in these regions include easy access to advanced technologies, government initiatives for cancer patient screening, favorable reimbursement scenarios for Anatomic Pathology Diagnostic Tests, increased healthcare expenditure, and the presence of high-quality infrastructure in hospitals and clinical laboratories.

Key Players

The "Anatomic Pathology Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as
Thermo Fisher Scientific, Agilent Technologies, F. Hoffmann-La Roche Ltd., Sakura Finetek, Danaher Corporation, Hologic, Inc., Merck KGaA, Bio SB, Becton, Dickinson and Company, and Diapath S.p.A.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Anatomic Pathology Market Key Developments

In September 2022, Epredia's parent company, PHC Holdings Corporation, strategically expanded its presence in Europe by acquiring anatomical pathology suppliers Microm Microtech France and Laurypath.
In July 2022, BillionToOne, a United States-based company, launched its first oncology liquid biopsy products, Northstar Select and Northstar Response.
In June 2022, Roche introduced the VENTANA DP 600 slide scanner, designed for digital pathology. This innovative technology is employed in anatomic pathology and bolsters patient care through precise diagnostics.

1 INTRODUCTION OF GLOBAL ANATOMIC PATHOLOGY MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL ANATOMIC PATHOLOGY MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL ANATOMIC PATHOLOGY MARKET, BY PRODUCT AND SERVICE

5.1 Overview
5.2 Instruments
5.3 Consumables
5.4 Services

6 GLOBAL ANATOMIC PATHOLOGY MARKET, BY APPLICATION

6.1 Overview
6.2 Disease Diagnosis
6.3 Drug Discovery and Development
6.4 Others

7 GLOBAL ANATOMIC PATHOLOGY MARKET, BY END-USER

7.1 Overview
7.2 Hospitals
7.3 Diagnostic Laboratories
7.4 Research Laboratories
7.5 Others

8 GLOBAL ANATOMIC PATHOLOGY MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East & Africa

9 GLOBAL ANATOMIC PATHOLOGY MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies

10 COMPANY PROFILES

10.1 Thermo Fisher Scientific
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 Agilent Technologies
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 F. Hoffmann-La Roche Ltd.
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 Sakura Finetek
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 Danaher Corporation
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 Hologic, Inc.
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 Merck KGaA
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 Bio SB
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.9 Becton, Dickinson and Company
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
10.10 Diapath S.p.A.
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments